Comparative review highlights regulatory gaps in regenerative therapies, suggesting necessary global collaboration.
This comparative review underscores the importance of harmonizing regulatory standards to ensure equitable access to regenerative therapies worldwide. International collaboration, knowledge sharing, and capacity building are crucial for bridging existing gaps, particularly in emerging markets like India, and for maintaining high standards of safety and efficacy globally.
No takes yet. Share an insight, caveat, or question.
Ghatak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: